Related Experiment Video
Updated: Mar 15, 2026

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
Published on: March 18, 2014
Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment
Juan Carlos Higareda-Almaraz1,2, Juan S Ruiz-Moreno1,3, Jana Klimentova4
1Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 242, 69120, Heidelberg, Germany.
Background:
Galectin-7 (Gal-7) is negatively regulated in cervical cancer, and appears to be a link between the apoptotic response triggered by cancer and the anti-tumoral activity of the immune system. Our understanding of how cervical cancer cells and their molecular networks adapt in response to the expression of Gal-7 remains limited.
Methods:
Meta-analysis of Gal-7 expression was conducted in three cervical cancer cohort studies and TCGA. In silico prediction and bisulfite sequencing were performed to inquire epigenetic alterations. To study the effect of Gal-7 on cervical cancer, we ectopically re-expressed it in the HeLa and SiHa cervical cancer cell lines, and analyzed their transcriptome and SILAC-based proteome. We also examined the tumor and microenvironment host cell transcriptomes after xenotransplantation into immunocompromised mice. Differences between samples were assessed with the Kruskall-Wallis, Dunn's Multiple Comparison and T tests. Kaplan-Meier and log-rank tests were used to determine overall survival.
Results:
Gal-7 was constantly downregulated in our meta-analysis (p < 0.0001). Tumors with combined high Gal-7 and low galectin-1 expression (p = 0.0001) presented significantly better prognoses (p = 0.005). In silico and bisulfite sequencing assays showed de novo methylation in the Gal-7 promoter and first intron. Cells re-expressing Gal-7 showed a high apoptosis ratio (p < 0.05) and their xenografts displayed strong growth retardation (p < 0.001). Multiple gene modules and transcriptional regulators were modulated in response to Gal-7 reconstitution, both in cervical cancer cells and their microenvironments (FDR < 0.05 %). Most of these genes and modules were associated with tissue morphogenesis, metabolism, transport, chemokine activity, and immune response. These functional modules could exert the same effects in vitro and in vivo, even despite different compositions between HeLa and SiHa samples.
Conclusions:
Gal-7 re-expression affects the regulation of molecular networks in cervical cancer that are involved in diverse cancer hallmarks, such as metabolism, growth control, invasion and evasion of apoptosis. The effect of Gal-7 extends to the microenvironment, where networks involved in its configuration and in immune surveillance are particularly affected.
Insights
Galectin-7 (Gal-7) is downregulated in cervical cancer, but its re-expression inhibits tumor growth and impacts immune response. This study reveals Gal-7
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Galectin-7 (Gal-7) is downregulated in cervical cancer, potentially linking cancer apoptosis and immune response.
- Limited understanding exists on how cervical cancer cells adapt to Gal-7 expression changes.
Purpose of the Study:
- To investigate the role of Galectin-7 (Gal-7) in cervical cancer.
- To explore the molecular mechanisms and consequences of Gal-7 re-expression in cervical cancer cells and their microenvironment.
Main Methods:
- Meta-analysis of Gal-7 expression in cervical cancer cohorts.
- In silico prediction and bisulfite sequencing for epigenetic analysis.
- Ectopic re-expression of Gal-7 in cervical cancer cell lines (HeLa, SiHa) followed by transcriptome and proteome analysis.
- Xenotransplantation studies to examine tumor and microenvironment responses.
Main Results:
- Galectin-7 (Gal-7) was significantly downregulated in cervical cancer.
- High Gal-7 and low galectin-1 expression correlated with better patient prognosis.
- Gal-7 re-expression induced apoptosis, inhibited tumor xenograft growth, and modulated gene networks involved in metabolism, morphogenesis, and immune response.
- Epigenetic analysis revealed de novo methylation in the Gal-7 promoter.
Conclusions:
- Galectin-7 (Gal-7) re-expression influences molecular networks critical for cervical cancer hallmarks, including metabolism, growth, invasion, and apoptosis evasion.
- Gal-7 impacts the tumor microenvironment, affecting networks involved in its configuration and immune surveillance.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
07:46Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
Published on: October 13, 2023